All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 199 of 206 pages ‹ First  < 197 198 199 200 201 >  Last ›

HSL3038
Johnston TS.
Provision of medicines in Ecuador.
Lancet 1980 May 17;1:(8177):1073-4

HSL1609
Palmisano P, Edelstein J.
Teaching drug promotion abuses to health profession students.
J Med Educ 1980 May;55:(5):453-5

HSL3040
King E.
Sex bias in psychoactive drug advertisements.
Psychiatry 1980 May;43:(2):129-37

HSL3041
Manning PR, Denson TA.
How internists learned about cimetidine.
Ann Intern Med 1980 May;92:(5):690-2

HSL3055
Joan SW.
Keeping prescription drug advertising honest: FDA's watchful eye
American Pharmacy 1980 May;20:(5):40-44

HSL3056
Woody E Jr.
The paradox of pharmaceutical advertising.
J Med Assoc Ga 1980 May;69:(5):379

HSL3032
Hemminki E.
Study of information submitted by drug companies to licensing authorities.
Br Med J 1980 Mar 22;280:(6217):833-6

HSL3054
Babich F, Moore J.
Prescription drug advertising
Medical Journal of Australia 1980 Mar 22;67:282

HSL8539
Glaser M.
Healthy drug market forecast for 1980
Drug Topics 1980 Mar 14;124:47-48, 61

HSL3053
Bell RW, Osterman J.
The Compendium of Pharmaceuticals and Specialties: a critical analysis
1980 Mar;19

HSL8544
York P.
Ujamaa (participatory socialism) for pharmacy in Tanzania
Pharm Int 1980 Mar;1:8-11

HSL8545
Wolfe SM.
Real targets: doctors, drug firms
FDA Consumer 1980 Feb;14:13

HSL3030
Goyan JE.
Who reviews the ads?
N Engl J Med 1980 Jan 31;302:(5):296

HSL3047
Thron CD.
Who reviews the ads?
N Engl J Med 1980 Jan 31;302:(5):295

HSL3049
Youman JD.
Who reviews the ads?
N Engl J Med 1980 Jan 31;302:(5):295

HSL3050
Young RS.
Who reviews the ads?
N Engl J Med 1980 Jan 31;302:(5):295-6

HSL3045
Stinson ER, Mueller DA.
Survey of health professionals' information habits and needs. Conducted through personal interviews
JAMA. 1980 Jan 11;243(2):140-3 1980 Jan 11;243:(2):140-3

HSL8542
Kane RE.
Environmental analysis of the prescription drug industry
Drug Information Journal 1980 Jan 3;14:20-23

HSL2340
Walton H.
Ad Recognition and Prescribing by Physicians
Journal of Advertising Research 1980;20:(3):39-48

HSL3025
Ethics and drug ads—a slip up in Bangladesh
1980;208:268-269

HSL3026
Colville P.
New material for medical representatives pharmacology course
Pharmaceutical Journal of New Zealand 1980;42:(6):5-7

HSL3027
Darvall LW.
The pharmaceutical industry: Prescription drug information controls in Australia and the United States
Monash University Law Review 1980;7:39-51

HSL3031
Gray BV.
Trade displays at medical conferences
New Zealand Medical Journal 1980;92:401

HSL3034
Hibberd P.
Use of drug information sources by hospital doctors
Journal of Information Science 1980;2:169-172

HSL3035
Hurd P.
The potential value of unfavorable information
Medical Marketing & Media 1980;15:(5):42-44, 46

HSL3036
Hutchinson G.
Prescribing drugs—generic vs trade names
McGill Medical Journal 1980;46:(1):2-6

HSL3037
Hymans R.
Trade displays at medical conferences
New Zealand Medical Journal 1980;92:329-330

HSL3039
Kellen A, Vandor T.
Commercial interruptions
Canadian Medical Association Journal 1980;123:12

HSL3042
Rheinstein P, Baum CS.
Labeling effectiveness and the health environment
1980;6:275-287

HSL3043
Rivin AU.
"Ethical" drugs.
Pharos Alpha Omega Alpha Honor Med Soc 1980 Spr;43:(2):9-10

HSL3044
Stephenson PS, Walker GA.
Psychotropic drugs and women
Bioethics Quarterly 1980;2:(1):20-38

HSL3048
Woods D.
And now, a word for our sponsor . . .
Canadian Medical Association Journal 1980;122:1343

HSL3052
Yudkin JS.
The economics of pharmaceutical supply in Tanzania.
Int J Health Serv 1980;10:(3):455-77

HSL9046
Conrad P, Schneider JW.
Deviance and Medicalization: From Badness to Sickness
St Louis: Mosby/Temple University Press 1980
http://www.temple.edu/tempress/titles/890_reg.html

HSL9088
Temin P.
Taking Your Medicine: Drug Regulation in the US
: Harvard Univ Press 1980
http://www.hup.harvard.edu/catalog/TEMTAK.html

HSL3024
Chapman S.
Prescription drug advertising
Medical Journal of Australia 1979 Nov 29;66:700

HSL3023
Ferris JD.
Prescription drug advertising
Medical Journal of Australia 1979 Nov 17;66:550

HSL2990
Feinstein AR, Horwitz RI.
Avoiding conflicts of interest in drug research.
N Engl J Med 1979 Nov 1;301:(18):1009

HSL2993
Greenberg BG.
Avoiding conflicts of interest in drug research.
N Engl J Med 1979 Nov 1;301:(18):1008

HSL3004
Relman AS.
Who reviews the ads?
N Engl J Med 1979 Nov 1;301:(18):999

HSL3022
Tannock IF.
Responsibility in advertising: an oncologist's view
New England Journal of Medicine 1979 Nov 1;300:1004

HSL2987
Chapman S.
Advertising and psychotropic drugs: the place of myth in ideological reproduction.
Soc Sci Med [Med Psychol Med Sociol] 1979 Nov;13A:(6):751-64

HSL3021
Kleinman G.
The physician’s drug adoption process re: product risk
Medical Marketing & Media 1979 Nov;14:46, 48-50

HSL16701
Wolfe S
The Conflict Between Individual Freedom and Social Control: Saccharin and Food Additives
Ann N.Y. Acad. Sci 1979 Nov;329:42‑245

HSL16702
Wolfe S
The Dichotomy Between Theory and Practice in Risk/Benefit Analysis
Ann N.Y. Acad. Sci 1979 Nov;329:274‑276

HSL8546
Leclerc Chevalier D
Ottawa report: Bureau of Drug Quality Assessment
Canadian Pharmaceutical Journal 1979 Oct;112:293-294

HSL8550
Fink JL.
Marketing in a generic environment: pharmacist's view
Medical Marketing and Media 1979 Oct;14:40, 42, 44, 46

HSL3017
Dukes MN.
Identifying the medical consultants of pharmaceutical companies.
Lancet 1979 Sep 29;2:(8144):696

HSL2991
Fitzgerald FT.
Detail men in white coats.
N Engl J Med 1979 Sep 20;301:(12):668

HSL3016
Burley DM.
Identifying the medical consultants of pharmaceutical companies.
Lancet 1979 Aug 18;2:(8138):354

HSL3002
Petsonk EL.
Conflicts of interest in drug research.
N Engl J Med 1979 Aug 9;301:(6):335

HSL8551
Barbieri J.
New prescription drug labeling requirement
US Pharmacist 1979 Aug;4:19-21

HSL3015
Lunde PK, Herxheimer A.
Identifying the medical consultants of pharmaceutical companies.
Lancet 1979 Jul 28;2:(8135):197

HSL3008
Solomon F, Mendelson WB.
Sleeping pills.
N Engl J Med 1979 Jul 26;301:(4):214-5

HSL3014
Kelly NR.
Prescription drug advertising
Medical Journal of Australia 1979 Jul 14;66:40

HSL3006
Schwartz H.
Junk mail.
N Engl J Med 1979 Jul 5;301:(1):53

HSL3007
Snead OC.
Junk mail.
N Engl J Med 1979 Jul 5;301:(1):53

HSL3010
Stock SL.
Junk mail.
N Engl J Med 1979 Jul 5;301:(1):53

HSL8547
Najman JM, Siskind V, Bain C.
Prescription drug advertising: medical journal practices under different types of control.
Med J Aust 1979 May 19;1:(10):420-4

HSL2988
Christensen DB, Wertheimer AI.
Sources of information and influence on new drug prescribing among physicians in an HMO.
Soc Sci Med 1979 May;13A:(3):313-22

HSL2980
Binns TB, Smith A.
Medical representatives.
Br Med J 1979 Apr 28;1:(6171):1134-5

HSL3005
Relman AS.
The sulindac story: what is medical news?
N Engl J Med 1979 Mar 29;300:(13):733-4

HSL3011
Thompson EL.
Sexual bias in drug advertisements.
Soc Sci Med 1979 Mar;13A:(2):187-91

HSL8541
Independents: holding their own
National Association of Retail Druggists Journal 1979 Mar;101:23-24

HSL3012
Wasner C, Kotzin B.
Sulindac "public relations" deplored.
N Engl J Med 1979 Feb 15;300:(7):373

HSL1878
Kaplan NM.
Sounding Boards.The support of continuing medical education by pharmaceutical companies
N Engl J Med 1979 Jan 25;300:(4):194-6

HSL3009
Solomon SD, Grimmett BL, Maurer KH, Levin NW.
Complaint about promotion of new anti-arthritic drug.
N Engl J Med 1979 Jan 25;300:(4):203

HSL2996
Lion JR, Regan BL, Taylor RJ, Kutzer DJ.
Psychiatrists' opinions of psychotropic drug advertisements.
Soc Sci Med [Med Psychol Med Sociol] 1979 Jan;13A:(1):123-5

HSL2989
Editor .
Publicity about sulindac [Editor's reply]
New England Journal of Medicine 1979;300:(13):735

HSL2992
Frisof KB, Parnicky K.
The burden of junk mail
New England Journal of Medicine 1979;300:865-866

HSL2994
Hughes R, Brewin R.
The tranquilizing of America: pill popping and the American way of life
1979;

HSL2995
Kaplan NM.
The support of continuing medical education by pharmaceutical companies
New England Journal of Medicine 1979;300:194-196

HSL2997
Lobo F.
Monopolistic structures and industrial analysis in Spain: the case of the pharmaceutical industry.
Int J Health Serv 1979;9:(4):663-82

HSL2998
Mallace AH.
Publicity about sulindac [2nd of 4 letters]
New England Journal of Medicine 1979;300:(13):734

HSL2999
Martin RW.
Diuretic equivalence of frusemide preparations
New Zealand Medical Journal 1979;90:209

HSL3000
Miller DR.
Publicity about sulindac [3rd of 4 letters]
New England Journal of Medicine 1979;300:(13):735

HSL3001
Miller JA, Waller R.
Health care advertising: consumer vs. physician attitudes
Journal of Advertising 1979;8:(4):20-29

HSL3003
Pyeritz RE.
The burden of junk mail
New England Journal of Medicine 1979;301:866

HSL9077
Medawar C.
Insult or Injury
London: Social Audit 1979
http://www.amazon.co.uk/Insult-Injury-Charles-Medawar/dp/0950339210/ref=sr_1_6/026-0515181-7375631?ie=UTF8&s=books&qid=1175254557&sr=1-6

HSL2958
Green B.
The politics of psychoactive drug use in old age.
Gerontologist 1978 Dec;18:(6):525-30

HSL2964
Kunin CM.
Clinical investigators and the pharmaceutical industry.
Ann Intern Med 1978 Nov;89:(5):

HSL8559
Kunin CM.
Problem of antibiotic usage. Definitions, causes, and proposed solutions
Ann Intern Med. 1978 Nov;89:(5):802-5.

HSL2963
Kalb CC.
Psychological motivations in physician prescribing habits.
Med Mark Media 1978 Oct;13:(10):43-5,

HSL8549
Kalb CL.
Psychological motivations in physician prescribing habits
Medical Marketing and Media 1978 Oct;13:43-45, 49, 50, 52, 54, 55

HSL8553
What companies do pharmacists now select when filling Rx's for 16 generic drugs? Part 2
Pharmacy Times 1978 Oct;44:45-49

HSL2314
Dajda R.
Drug advertising and prescribing.
J R Coll Gen Pract 1978 Sep;28:(194):538-41
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=739456&query_hl=23

HSL2973
Talley CR.
Hospitals defend formulary decisions against industry attacks.
Am J Hosp Pharm 1978 Sep;35:(9):1154-5

HSL8552
What companies do pharmacists now select when filling Rx's for 16 generic drugs? Part 1
Pharmacy Times 1978 Sep;44:54-58

HSL16700
Wolfe S
Now, Let the Victim Beware
Mother Jones 1978 Sep14-18

HSL2972
Shearer SW, Gagnon JP, Eckel FM.
Community, hospital and clinical pharmacists and drug information centers as physician drug information sources.
Am J Hosp Pharm 1978 Aug;35:(8):909-14

HSL2976
Walton H.
A case for medical journal advertising
Medical Marketing & Media 1978 Aug;13:37-43

HSL8560
Gardner VR, Fulda TR.
Drug insurance and cost containment: an evaluation of where we're going.
Hosp Formul 1978 Jun;13:(6):460-1,

HSL3013
Paine TF.
Advertising (quantified)
JAMA1979 May 25;241(21):2264 1979 May 25;241:(21):2264

HSL8548
Braucher CL.
Pharmacy ethics-professional idealism and reality
American Journal of Pharmaceutical Education 1978 May;42:141-143

HSL2975
Peretz SM.
Medical journal advertising as currently viewed by the pharmaceutical industry.
J R Soc Med 1978 Apr;71:(4):282-4

HSL8561
Annual survey report-research and development activities ethical pharmaceutical industry, 1976 with forecast for 1977
Medical Marketing and Media 1978 Mar;13:17-18, 20-24, 26-30

HSL2957
Medical journals and advertising
N Z Med J. 1978 Feb 22;87:(606):139

HSL8555
Dolan M.
Target practice at FDA: talking back to the regulators
American Pharmacy 1978 Feb;36-40

HSL2971
Roustan PT.
The pharmaceutical manufacturers representative.
Drug Inf J 1978 Jan-Mar;12:(1):15-9

HSL8563
Garton WM.
Pharmaceutical industry in Canada: its environment and performance
Canadian Pharmaceutical Journal 1978 Jan;111:6-7

Page 199 of 206 pages ‹ First  < 197 198 199 200 201 >  Last ›